U/S Guided FNAC (SHM) at Dr. Essa Lab

U/S Guided FNAC (SHM) at Dr. Essa Lab

The U/S Guided FNAC (SHM) is a highly specialized, minimally invasive diagnostic procedure that combines real-time high-resolution ultrasound imaging with fine needle aspiration cytology. At Dr. Essa Lab, this procedure is primarily utilized to evaluate superficial head and neck masses, submandibular gland lesions, and other superficial swellings (often abbreviated as SHM). By utilizing advanced ultrasound guidance, our expert radiologists can visualize the exact location of the target lesion, ensuring that the biopsy needle is positioned with millimeter-level precision. This real-time visualization significantly increases the diagnostic yield of the sample while minimizing the risk of injury to adjacent vital structures, such as major blood vessels, salivary ducts, and nerves.

During the procedure, a very thin, fine-gauge needle is introduced into the target mass under direct ultrasound visualization. A small sample of cells is aspirated and immediately transferred to glass slides for cytological examination. The primary clinical importance of the U/S Guided FNAC (SHM) lies in its ability to rapidly and accurately differentiate between benign inflammatory conditions, cystic lesions, and malignant neoplasms. This diagnostic distinction is crucial for guiding subsequent clinical management, preventing unnecessary surgical interventions, and planning appropriate therapeutic strategies. Patients benefit from a virtually painless, outpatient procedure that requires no general anesthesia, leaves no surgical scars, and provides rapid, highly reliable diagnostic answers.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is essential to ensure patient safety and the collection of a high-quality diagnostic sample. Patients undergoing a U/S Guided FNAC (SHM) at Dr. Essa Lab should follow these guidelines:

• Medication Review: Inform your referring physician and the clinical team at Dr. Essa Lab if you are taking any blood-thinning medications, anticoagulants, or antiplatelet drugs (such as aspirin, clopidogrel, or warfarin). You may be advised to temporarily discontinue these medications a few days prior to the procedure, under medical supervision, to minimize the risk of localized bleeding or hematoma formation.
• Fasting Requirements: Generally, fasting is not required for a superficial ultrasound-guided fine needle aspiration. You may eat a light meal and drink fluids normally before your appointment.
• Clothing and Accessories: Wear comfortable, loose-fitting clothing, preferably a button-down shirt or a top with a wide neck, to allow easy access to the head, neck, or submandibular region. Please remove any jewelry, necklaces, or dangling earrings before the procedure.
• Medical Records: Bring all relevant previous diagnostic reports, including prior ultrasound scans, CT scans, MRI reports, and blood test results, to assist the radiologist in targeting the lesion accurately.
• Allergies: Inform the medical staff if you have any known allergies to local anesthetics, antiseptic solutions (such as iodine or isopropyl alcohol), or latex.

During the Procedure

The U/S Guided FNAC (SHM) is performed in a dedicated, sterile interventional ultrasound suite at Dr. Essa Lab. The step-by-step process is designed to maximize patient comfort and diagnostic accuracy:

• Patient Positioning: You will be asked to lie down comfortably on an examination table, usually in a supine position (on your back) with your neck slightly extended and your head turned away from the side being evaluated. A pillow or support may be placed under your shoulders to optimize exposure of the target area.
• Ultrasound Mapping: The radiologist will apply a sterile, water-soluble gel to the skin over the target mass. Using a high-frequency linear ultrasound probe, the radiologist will perform a preliminary scan to evaluate the size, depth, vascularity, and internal characteristics of the mass, planning the safest and most direct path for the needle.
• Sterile Preparation: The skin over the target area is thoroughly cleansed with an antiseptic solution to maintain a sterile field and prevent infection.
• Anesthesia (Optional): Because the needle used for FNAC is extremely thin (often thinner than the needle used for a routine blood draw), local anesthesia is typically not required. However, a local anesthetic spray or a small injection of lidocaine may be applied to the skin if requested or if the lesion is deeply situated.
• Needle Insertion and Aspiration: Under continuous, real-time ultrasound monitoring, the radiologist gently inserts the fine needle through the skin and guides it directly into the target mass. Once the needle tip is confirmed to be inside the lesion, a small amount of cellular material is aspirated using gentle suction. The needle may be moved slightly back and forth within the lesion to collect a representative sample of cells.
• Procedure Duration: The actual aspiration process takes only a few seconds. The entire procedure, including ultrasound mapping, sterile preparation, and sample collection, is typically completed within 15 to 30 minutes.
• Post-Procedure Care: After the needle is withdrawn, firm manual pressure is applied to the site for several minutes to prevent bleeding and bruising. A small sterile bandage is then applied. You will be monitored briefly before being allowed to resume your normal daily activities.

When is a U/S Guided FNAC (SHM) Performed?

Evaluation of Palpable Neck and Submandibular Masses

Physicians frequently request a U/S Guided FNAC (SHM) when a patient presents with a palpable, unexplained lump or swelling in the neck or submandibular region. These masses can stem from various sources, including salivary glands, lymph nodes, or developmental cysts. The procedure is highly effective in determining whether the mass is solid or cystic, and whether it represents a benign inflammatory process or a neoplastic growth, allowing clinicians to establish an accurate diagnosis without resorting to open surgical biopsy.

Investigation of Suspected Thyroid Nodules

Thyroid nodules are highly common, and while the majority are benign, cytological evaluation is necessary to rule out malignancy. When an ultrasound scan reveals suspicious features within a thyroid nodule—such as microcalcifications, irregular margins, marked hypoechogenicity, or an extra-capsular extension—a U/S Guided FNAC is indicated. The procedure allows for the collection of follicular cells, which are then categorized using the standardized Bethesda System for Reporting Thyroid Cytopathology to guide clinical management.

Assessment of Salivary Gland Lesions

Swellings in the submandibular or parotid salivary glands can be caused by sialadenitis (inflammation), sialolithiasis (salivary stones), or salivary gland tumors. Because the salivary glands are surrounded by critical nerves and blood vessels, a blind biopsy is highly risky. U/S Guided FNAC (SHM) provides a safe, real-time guided method to sample these lesions, helping pathologists differentiate between benign tumors (such as pleomorphic adenoma or Warthin's tumor) and malignant salivary gland carcinomas.

Diagnosis of Persistent Lymphadenopathy

Enlarged lymph nodes in the neck (cervical lymphadenopathy) that persist for several weeks without an obvious infectious cause require thorough investigation. A U/S Guided FNAC is performed to evaluate these nodes for signs of reactive hyperplasia, chronic infections (such as tuberculosis, which is highly prevalent), lymphoma, or metastatic disease originating from primary cancers of the head, neck, or distant organs.

Characterization of Superficial Soft Tissue Swellings

Superficial soft tissue swellings, including subcutaneous nodules, epidermal inclusion cysts, lipomas, or vascular malformations, can sometimes mimic more serious conditions. When clinical examination and standard imaging are inconclusive, a U/S Guided FNAC (SHM) is performed to aspirate cells or fluid from the lesion. This assists the physician in confirming a benign diagnosis, such as a benign lipoma or a keratin-filled cyst, or identifying atypical mesenchymal cells that may require surgical excision.

What Does a U/S Guided FNAC (SHM) Detect?

A U/S Guided FNAC (SHM) is capable of detecting a wide spectrum of benign, inflammatory, infectious, and malignant conditions. Specific diagnostic findings include:

• Benign Follicular Thyroid Nodule: Characterized by abundant colloid and regular follicular cells, indicating a non-cancerous thyroid condition.
• Papillary Thyroid Carcinoma: Identified by classic nuclear features such as intranuclear inclusions, nuclear grooves, and psammoma bodies.
• Medullary Thyroid Carcinoma: Indicated by the presence of plasmacytoid or spindle-shaped cells with amyloid stroma.
• Anaplastic Thyroid Carcinoma: A highly aggressive malignancy characterized by marked cellular pleomorphism and atypical mitotic figures.
• Pleomorphic Adenoma: The most common benign salivary gland tumor, showing a mixture of epithelial elements and myxoid or chondromyxoid stroma.
• Warthin's Tumor (Cystadenolymphoma): A benign salivary gland lesion characterized by bilayered oncocytic epithelium and a lymphoid stroma.
• Mucoepidermoid Carcinoma: A malignant salivary gland tumor showing a mixture of mucin-producing, intermediate, and squamous cells.
• Adenoid Cystic Carcinoma: A malignant salivary neoplasm characterized by cohesive clusters of small, uniform cells forming a cribriform (swiss-cheese) pattern.
• Reactive Lymphoid Hyperplasia: A benign, self-limiting enlargement of lymph nodes in response to localized infection or systemic inflammation.
• Tuberculous Lymphadenitis: Characterized by necrotizing granulomatous inflammation, epithelioid histiocytes, Langhans giant cells, and dirty necrotic debris.
• Suppurative Lymphadenitis: Indicated by an abundance of polymorphonuclear neutrophils and necrotic cellular debris, pointing to an acute bacterial infection.
• Hodgkin Lymphoma: Suggested by the presence of diagnostic Reed-Sternberg cells in a background of mixed inflammatory cells.
• Non-Hodgkin Lymphoma: Characterized by a monomorphic population of atypical lymphoid cells, requiring further immunocytochemical or histopathological confirmation.
• Metastatic Squamous Cell Carcinoma: Identified by cohesive sheets of highly atypical, keratinizing or non-keratinizing squamous epithelial cells in a cervical lymph node.
• Metastatic Adenocarcinoma: Indicated by malignant glandular cells, often forming clusters or acinar structures, metastasized from a primary site like the lungs, breast, or GI tract.
• Epidermal Inclusion Cyst: Confirmed by the aspiration of thick, greasy material containing abundant anucleated squamous cells and keratin debris.
• Benign Lipoma: Indicated by mature, uniform adipocytes without cytological atypia or lipoblasts.
• Branchial Cleft Cyst: Characterized by the aspiration of thin, straw-colored fluid containing mature squamous cells and cholesterol crystals.
• Thyroglossal Duct Cyst: Indicated by mucoid fluid containing ciliated columnar or squamous epithelial cells, often with thyroid follicular cells in the background.
• Acute or Chronic Sialadenitis: Characterized by salivary gland acinar cells showing degenerative changes, accompanied by acute or chronic inflammatory cells.
• Sialolithiasis-Associated Changes: Indicated by squamous metaplasia of ductal cells and chronic inflammatory cells secondary to ductal obstruction.
• Hashimoto's Thyroiditis: Characterized by a prominent lymphocytic infiltrate, Hurthle cells (oncocytes), and scant colloid.
• De Quervain's (Subacute) Thyroiditis: Indicated by multinucleated giant cells, degenerating follicular cells, and mixed inflammatory cells.
• Pilomatricoma: A benign skin adnexal tumor characterized by ghost cells, basaloid cells, and foreign body giant cells.
• Malignant Melanoma Metastasis: Identified by highly atypical, pigmented or non-pigmented cells with prominent macronucleoli.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that waiting for diagnostic results can be a source of anxiety for patients and their families. The cellular material obtained during your U/S Guided FNAC (SHM) is processed immediately using advanced staining techniques, including Papanicolaou (Pap), May-Grünwald-Giemsa (MGG), or Hematoxylin and Eosin (H&E) stains. Our highly experienced cytopathologists meticulously examine the slides under high-power microscopes to ensure diagnostic accuracy.

The final diagnostic report for a U/S Guided FNAC (SHM) is typically ready within 24 to 48 hours, depending on the complexity of the case and whether special stains or cell block preparations are required. Dr. Essa Lab provides seamless and convenient access to your diagnostic reports. Patients can easily view, download, and print their reports online via the official Dr. Essa Lab website or patient portal. Additionally, SMS notifications are sent to patients as soon as their reports are verified, and physical copies can be collected from any of our conveniently located diagnostic centers across Karachi and other cities.

U/S Guided FNAC (SHM) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Thyroid Gland	Uniform follicular cells, abundant thin colloid, no cellular atypia.	Hypercellularity, microcalcifications, nuclear grooves, papillary clusters (suggestive of malignancy).
Submandibular / Salivary Glands	Normal salivary acini and ductal epithelial cells, clean background.	Pleomorphic epithelial cells, myxoid stroma, atypical squamous cells, mucin-producing cells.
Cervical Lymph Nodes	Polymorphous population of mature lymphocytes, no atypical cells.	Monomorphic atypical lymphoid cells, granulomas, caseous necrosis, metastatic epithelial cells.
Superficial Soft Tissue	Normal subcutaneous fat, fibrous tissue, or skin adnexal structures.	Atypical spindle cells, abundant keratin debris, mature adipocytes forming a distinct mass.
Cellular Adequacy	Sufficient diagnostic cellular material present on slides.	Inadequate cellularity, excessive blood obscuring details, necrotic debris only (requires repeat biopsy).
Background Matrix	Clean background or normal physiological fluids (e.g., thin colloid).	Thick colloid, necrotic debris, acute inflammatory exudate, mucinous or chondromyxoid matrix.
Nuclear Morphology	Regular, round nuclei with smooth membranes and evenly distributed chromatin.	Pleomorphism, hyperchromasia, prominent nucleoli, intranuclear inclusions, atypical mitotic figures.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for U/S Guided FNAC (SHM)?

• Experienced Healthcare Professionals: Our procedures are performed by highly skilled radiologists and interpreted by senior cytopathologists with extensive experience in head and neck pathology.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the diagnostic process.
• Quality Diagnostic Services: Dr. Essa Lab is committed to delivering the highest standards of diagnostic accuracy, utilizing strict quality control protocols.
• Professional Reporting: Detailed, structured, and clinically actionable reports that assist referring physicians in making timely treatment decisions.
• Modern Diagnostic Approach: We utilize high-resolution ultrasound systems to ensure precise needle placement and optimal sample collection.
• Comfortable Environment: Our diagnostic centers are designed to provide a clean, sterile, and reassuring environment for all patients.
• Convenient Location: With a vast network of branches across Karachi and other major cities, accessing our services is easy and convenient.
• Commitment to Accurate Diagnosis: Established in 1987, Dr. Essa Lab has built decades of trust through reliable, evidence-based diagnostic services.